Tapewire

Nasdaq · USD

SRTS

Sensus Healthcare, Inc.

Export transactions ↓
Tapewire entity
7142
SEC CIK
0001494891
Parsed reports
184

Last 12 months

Inside the activity.

21 purchase rows · 0 sale rows

Disclosed non-derivative P/S rows, by transaction month. Includes amendments and private transactions.
Monthly counts
MonthPurchasesSales
Nov 2025110
Dec 202500
Jan 202600
Feb 202610
Mar 202600
Apr 202600
May 202610
Jun 202600
Jul 202600
Aug 202680
Sep 202600
Oct 202600

Latest available

Insider transactions

JSON API
Reset

Purchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”

The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.

Transaction dateOwner / reported roleActivity / securityShares / unitsReported priceReported valueDetails
August 31, 2026 Filed Aug 31, 2026 16:35 UTC PurchaseCommon Stock 27,304 $3.54 $96,601.55
Disclosure

SEC source: 0002097345-26-000016 · form4-08312026_040829.xml · nonDerivative · entry 2

Sachetta Eric · CIK 0002097345 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 294,784

Read SEC document
August 28, 2026 Filed Aug 31, 2026 16:35 UTC PurchaseCommon Stock 37,537 $3.44 $129,014.67
Disclosure

SEC source: 0002097345-26-000016 · form4-08312026_040829.xml · nonDerivative · entry 1

Sachetta Eric · CIK 0002097345 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 267,480

Read SEC document
August 27, 2026 Filed Aug 28, 2026 18:29 UTC PurchaseCommon Stock 10,925 $3.18 $34,752.43
Disclosure

SEC source: 0002097345-26-000014 · form4-08282026_060815.xml · nonDerivative · entry 2

Sachetta Eric · CIK 0002097345 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 229,943

Read SEC document
August 26, 2026 Filed Aug 28, 2026 18:29 UTC PurchaseCommon Stock 9,708 $3.29 $31,929.61
Disclosure

SEC source: 0002097345-26-000014 · form4-08282026_060815.xml · nonDerivative · entry 1

Sachetta Eric · CIK 0002097345 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 219,018

Read SEC document
August 24, 2026 Filed Aug 25, 2026 13:26 UTC PurchaseCommon Stock 34,697 $3.25 $112,904.04
Disclosure

SEC source: 0002097345-26-000012 · form4-08252026_010829.xml · nonDerivative · entry 1

Sachetta Eric · CIK 0002097345 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 209,310

Read SEC document
August 21, 2026 Filed Aug 24, 2026 19:08 UTC PurchaseCommon Stock 7,000 $3.25 $22,778.00
Disclosure

SEC source: 0002097345-26-000010 · form4-08242026_070802.xml · nonDerivative · entry 2

Sachetta Eric · CIK 0002097345 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 174,613

Read SEC document
August 20, 2026 Filed Aug 24, 2026 20:00 UTC
Sardano Joseph CDirector · CHIEF EXECUTIVE OFFICER
PurchaseCommon Stock 20,000 $3.02 $60,486.00
Disclosure

SEC source: 0001300111-26-000002 · form4-08242026_080806.xml · nonDerivative · entry 1

Sardano Joseph C · CIK 0001300111 · Director · CHIEF EXECUTIVE OFFICER

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 1,220,293

Read SEC document
August 20, 2026 Filed Aug 24, 2026 19:08 UTC PurchaseCommon Stock 24,000 $3.13 $75,072.00
Disclosure

SEC source: 0002097345-26-000010 · form4-08242026_070802.xml · nonDerivative · entry 1

Sachetta Eric · CIK 0002097345 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 167,613

Read SEC document
May 12, 2026 Filed May 12, 2026 17:53 UTC PurchaseCommon Stock 1,500 $3.34 $5,002.50
Disclosure

SEC source: 0002097345-26-000008 · form4-05122026_050542.xml · nonDerivative · entry 1

Sachetta Eric · CIK 0002097345 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 143,613

Read SEC document
February 24, 2026 Filed Feb 26, 2026 14:25 UTC PurchaseCommon Stock 2,000 $3.81 $7,620.00
Disclosure

SEC source: 0002097345-26-000004 · form4-02262026_020228.xml · nonDerivative · entry 1

Sachetta Eric · CIK 0002097345 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 142,113

F1 · price: Represents the average price per share.

Read SEC document
December 12, 2025 Filed Dec 16, 2025 19:40 UTC
Sardano MichaelDirector · PRESIDENT AND GENERAL COUNSEL
GrantCommon Stock 40,000 $0.00 $0.00
Disclosure

SEC source: 0001720602-25-000015 · form4-12162025_071217.xml · nonDerivative · entry 1

Sardano Michael · CIK 0001720602 · Director · PRESIDENT AND GENERAL COUNSEL

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 158,839

F1 · shares: Represents 40,000 shares of restricted stock granted to the reporting person pursuant to the Sensus Healthcare, Inc. 2017 Equity Incentive Plan, all of which will vest in four equal annual installments beginning on the first anniversary of the date of grant.

Read SEC document
November 21, 2025 Filed Nov 21, 2025 19:28 UTC PurchaseCommon Stock 7,000 $3.93 $27,510.00
Disclosure

SEC source: 0002097345-25-000008 · form4-11212025_071127.xml · nonDerivative · entry 1

Sachetta Eric · CIK 0002097345 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 140,113

Read SEC document
November 18, 2025 Filed Nov 19, 2025 14:34 UTC
Sardano Joseph CDirector · CHIEF EXECUTIVE OFFICER
PurchaseCommon Stock 25,000 $4.03 $100,750.00
Disclosure

SEC source: 0001300111-25-000005 · form4-11192025_021106.xml · nonDerivative · entry 1

Sardano Joseph C · CIK 0001300111 · Director · CHIEF EXECUTIVE OFFICER

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 1,200,293

F1 · price: Represents the average price per share.

Read SEC document
November 18, 2025 Filed Nov 19, 2025 14:15 UTC
Sardano MichaelDirector · PRESIDENT AND GENERAL COUNSEL
PurchaseCommon Stock 1,000 $3.80 $3,800.00
Disclosure

SEC source: 0001720602-25-000011 · form4-11192025_021158.xml · nonDerivative · entry 1

Sardano Michael · CIK 0001720602 · Director · PRESIDENT AND GENERAL COUNSEL

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 118,839

Read SEC document
November 13, 2025 Filed Nov 20, 2025 19:03 UTC PurchaseCommon Stock 2,500 $4.50 $11,250.00
Disclosure

SEC source: 0002097345-25-000006 · form4-11202025_071107.xml · nonDerivative · entry 1

Sachetta Eric · CIK 0002097345 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 133,113

Read SEC document
November 11, 2025 Filed Nov 12, 2025 14:53 UTC
Sardano MichaelDirector · PRESIDENT AND GENERAL COUNSEL
PurchaseCommon Stock 1,000 $4.26 $4,260.00
Disclosure

SEC source: 0001720602-25-000004 · form4-11122025_021118.xml · nonDerivative · entry 1

Sardano Michael · CIK 0001720602 · Director · PRESIDENT AND GENERAL COUNSEL

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 117,839

Read SEC document
November 11, 2025 Filed Nov 13, 2025 14:06 UTC Amendment
Sardano MichaelDirector · PRESIDENT AND GENERAL COUNSEL
PurchaseCommon Stock 234 $4.24 $992.16
Disclosure

SEC source: 0001720602-25-000007 · form4a-11132025_021148.xml · nonDerivative · entry 3

Sardano Michael · CIK 0001720602 · Director · PRESIDENT AND GENERAL COUNSEL

10b5-1 filing: No plan indicated

Ownership: Indirect · spouse

Disclosed balance after: 118,839

F1 · ownership.nature: Shares held by Mr. Sardano's spouse, as to which he disclaims beneficial ownership.

Read SEC document
November 11, 2025 Filed Nov 13, 2025 14:06 UTC Amendment
Sardano MichaelDirector · PRESIDENT AND GENERAL COUNSEL
PurchaseCommon Stock 766 $4.27 $3,270.82
Disclosure

SEC source: 0001720602-25-000007 · form4a-11132025_021148.xml · nonDerivative · entry 2

Sardano Michael · CIK 0001720602 · Director · PRESIDENT AND GENERAL COUNSEL

10b5-1 filing: No plan indicated

Ownership: Indirect · spouse

Disclosed balance after: 118,605

F1 · ownership.nature: Shares held by Mr. Sardano's spouse, as to which he disclaims beneficial ownership.

Read SEC document
November 11, 2025 Filed Nov 13, 2025 14:06 UTC Amendment
Sardano MichaelDirector · PRESIDENT AND GENERAL COUNSEL
PurchaseCommon Stock 1,000 $4.26 $4,260.00
Disclosure

SEC source: 0001720602-25-000007 · form4a-11132025_021148.xml · nonDerivative · entry 1

Sardano Michael · CIK 0001720602 · Director · PRESIDENT AND GENERAL COUNSEL

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 117,839

Read SEC document
November 11, 2025 Filed Nov 18, 2025 21:31 UTC Amendment
Sardano MichaelDirector · PRESIDENT AND GENERAL COUNSEL
PurchaseCommon Stock 234 $4.34 $1,015.56
Disclosure

SEC source: 0001720602-25-000010 · form4a-11182025_091144.xml · nonDerivative · entry 3

Sardano Michael · CIK 0001720602 · Director · PRESIDENT AND GENERAL COUNSEL

10b5-1 filing: No plan indicated

Ownership: Indirect · spouse

Disclosed balance after: 1,000

F1 · ownership.nature: Shares held by Mr. Sardano's spouse, as to which he disclaims beneficial ownership.

Read SEC document
November 11, 2025 Filed Nov 18, 2025 21:31 UTC Amendment
Sardano MichaelDirector · PRESIDENT AND GENERAL COUNSEL
PurchaseCommon Stock 766 $4.27 $3,270.82
Disclosure

SEC source: 0001720602-25-000010 · form4a-11182025_091144.xml · nonDerivative · entry 2

Sardano Michael · CIK 0001720602 · Director · PRESIDENT AND GENERAL COUNSEL

10b5-1 filing: No plan indicated

Ownership: Indirect · spouse

Disclosed balance after: 766

F1 · ownership.nature: Shares held by Mr. Sardano's spouse, as to which he disclaims beneficial ownership.

Read SEC document
November 11, 2025 Filed Nov 18, 2025 21:31 UTC Amendment
Sardano MichaelDirector · PRESIDENT AND GENERAL COUNSEL
PurchaseCommon Stock 1,000 $4.26 $4,260.00
Disclosure

SEC source: 0001720602-25-000010 · form4a-11182025_091144.xml · nonDerivative · entry 1

Sardano Michael · CIK 0001720602 · Director · PRESIDENT AND GENERAL COUNSEL

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 117,839

Read SEC document
August 13, 2025 Filed Aug 14, 2025 15:06 UTC
Sardano MichaelDirector · PRESIDENT AND GENERAL COUNSEL
PurchaseCommon Stock 1,000 $3.37 $3,370.00
Disclosure

SEC source: 0001415889-25-021748 · form4-08142025_030832.xml · nonDerivative · entry 1

Sardano Michael · CIK 0001720602 · Director · PRESIDENT AND GENERAL COUNSEL

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 116,839

Read SEC document
February 10, 2025 Filed Feb 10, 2025 15:20 UTC
Rampolla JavierCHIEF FINANCIAL OFFICER
PurchaseCommon Stock 501 $5.95 $2,980.95
Disclosure

SEC source: 0001415889-25-003441 · form4-02102025_080252.xml · nonDerivative · entry 1

Rampolla Javier · CIK 0001800068 · CHIEF FINANCIAL OFFICER

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 40,745

Read SEC document
February 10, 2025 Filed Feb 10, 2025 20:16 UTC
Sardano MichaelDirector · PRESIDENT AND GENERAL COUNSEL
PurchaseCommon Stock 1,000 $5.95 $5,950.00
Disclosure

SEC source: 0001415889-25-003440 · form4-02102025_080258.xml · nonDerivative · entry 1

Sardano Michael · CIK 0001720602 · Director · PRESIDENT AND GENERAL COUNSEL

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 115,839

Read SEC document
December 17, 2024 Filed Dec 19, 2024 16:30 UTC GrantCommon Stock 20,000 $0.00 $0.00
Disclosure

SEC source: 0001415889-24-029865 · form4-12192024_091222.xml · nonDerivative · entry 1

McCall William H · CIK 0001670233 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 30,000

F1 · shares: Represents 20,000 shares of restricted stock granted to the reporting person pursuant to the Sensus Healthcare, Inc. 2017 Equity Incentive Plan which will vest in four equal annual installments beginning on the first anniversary of the date of grant.

Read SEC document
December 17, 2024 Filed Dec 19, 2024 21:34 UTC GrantCommon Stock 20,000 $0.00 $0.00
Disclosure

SEC source: 0001415889-24-029866 · form4-12192024_091203.xml · nonDerivative · entry 1

Petrelli Anthony Benedict · CIK 0001354750 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 66,466

F1 · shares: Represents 20,000 shares of restricted stock granted to the reporting person pursuant to the Sensus Healthcare, Inc. 2017 Equity Incentive Plan which will vest in four equal annual installments beginning on the first anniversary of the date of grant.

Read SEC document
December 17, 2024 Filed Dec 19, 2024 21:27 UTC GrantCommon Stock 20,000 $0.00 $0.00
Disclosure

SEC source: 0001415889-24-029853 · form4-12192024_091220.xml · nonDerivative · entry 1

Cornish Megan · CIK 0001832041 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 32,000

F1 · shares: Represents 20,000 shares of restricted stock granted to the reporting person pursuant to the Sensus Healthcare, Inc. 2017 Equity Incentive Plan which will vest in four equal annual installments beginning on the first anniversary of the date of grant.

Read SEC document
December 17, 2024 Filed Dec 19, 2024 20:15 UTC
Sardano MichaelDirector · PRESIDENT AND GENERAL COUNSEL
GrantCommon Stock 40,000 $0.00 $0.00
Disclosure

SEC source: 0001415889-24-029833 · form4-12192024_081237.xml · nonDerivative · entry 1

Sardano Michael · CIK 0001720602 · Director · PRESIDENT AND GENERAL COUNSEL

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 114,839

F1 · shares: Represents 40,000 shares of restricted stock granted to the reporting person pursuant to the Sensus Healthcare, Inc. 2017 Equity Incentive Plan, 10,000 of which vested on the date of grant and 30,000 of which will vest in three equal annual installments beginning on the first anniversary of the date of grant.

Read SEC document
July 21, 2024 Filed Jul 23, 2024 14:49 UTC
Rampolla JavierCHIEF FINANCIAL OFFICER
Tax withholdingCommon Stock 3,935 $6.00 $23,610.00
Disclosure

SEC source: 0001415889-24-019929 · form4-07232024_060749.xml · nonDerivative · entry 1

Rampolla Javier · CIK 0001800068 · CHIEF FINANCIAL OFFICER

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 40,244

F1 · shares: Represents shares withheld to pay the reporting person's withholding tax obligation arising solely in connection with the vesting of restricted stock.

Read SEC document
July 21, 2024 Filed Jul 23, 2024 18:48 UTC
Sardano MichaelDirector · PRESIDENT AND GENERAL COUNSEL
Tax withholdingCommon Stock 3,935 $6.00 $23,610.00
Disclosure

SEC source: 0001415889-24-019928 · form4-07232024_060733.xml · nonDerivative · entry 1

Sardano Michael · CIK 0001720602 · Director · PRESIDENT AND GENERAL COUNSEL

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 74,839

F1 · shares: Represents shares withheld to pay the reporting person's withholding tax obligation arising solely in connection with the vesting of restricted stock.

Read SEC document
May 20, 2024 Filed May 24, 2024 10:17 UTC SaleCommon Stock 15,227 $6.24 $95,016.48
Disclosure

SEC source: 0001415889-24-014417 · form4-05242024_020554.xml · nonDerivative · entry 2

Heinrich John · CIK 0001669988 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 59,940

Read SEC document
May 17, 2024 Filed May 24, 2024 10:17 UTC SaleCommon Stock 4,773 $5.95 $28,399.35
Disclosure

SEC source: 0001415889-24-014417 · form4-05242024_020554.xml · nonDerivative · entry 1

Heinrich John · CIK 0001669988 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 75,167

Read SEC document
January 11, 2024 Filed Jan 16, 2024 18:35 UTC
Sardano MichaelPRESIDENT AND GENERAL COUNSEL
GrantCommon Stock 20,000 $0.00 $0.00
Disclosure

SEC source: 0001415889-24-001064 · form4-01162024_060147.xml · nonDerivative · entry 1

Sardano Michael · CIK 0001720602 · PRESIDENT AND GENERAL COUNSEL

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 78,774

F1 · shares: Represents 20,000 shares of stock granted to the reporting person by a committee of non-employee directors in compliance with Rule 16b-3 and pursuant to the Sensus Healthcare, Inc. 2017 Equity Incentive Plan. 10,000 of these shares vested immediately. The remaining 10,000 shares will vest on January 11, 2025.

Read SEC document
December 19, 2023 Filed Dec 20, 2023 18:29 UTC
Martinez MagdalenaCHIEF OPERATING OFFICER
Tax withholdingCommon Stock 741 $2.66 $1,971.06
Disclosure

SEC source: 0001415889-23-016774 · form4-12202023_061226.xml · nonDerivative · entry 1

Martinez Magdalena · CIK 0001960987 · CHIEF OPERATING OFFICER

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 9,759

F1 · shares: Represents shares withheld to pay reporting person's withholding tax obligation arising solely in connection with the vesting of restricted stock.

Read SEC document
December 19, 2023 Filed Apr 22, 2026 20:13 UTC Amendment
Martinez MagdalenaCHIEF OPERATING OFFICER
Tax withholdingCommon Stock 741 $2.66 $1,971.06
Disclosure

SEC source: 0001960987-26-000004 · form4a-04222026_080428.xml · nonDerivative · entry 1

Martinez Magdalena · CIK 0001960987 · CHIEF OPERATING OFFICER

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 12,013

F1 · shares: Represents shares withheld to pay reporting person's withholding tax obligation arising solely in connection with the vesting of restricted stock.

F2 · balance_after: On December 20, 2023, the reporting person filed a Form 4 which inadvertently reported that the reporting person owned 9,759 shares of the issuer's common stock as of December 19, 2023. In fact, the reporting person held 12,013 shares of the issuer's common stock (including 7,500 shares of restricted stock) as of December 19, 2023.

Read SEC document
September 14, 2023 Filed Sep 18, 2023 15:04 UTC
Sardano Joseph CDirector · CHIEF EXECUTIVE OFFICER
PurchaseCommon Stock 10,000 $2.88 $28,773.00
Disclosure

SEC source: 0001415889-23-013321 · form4-09182023_030948.xml · nonDerivative · entry 1

Sardano Joseph C · CIK 0001300111 · Director · CHIEF EXECUTIVE OFFICER

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 1,175,293

F1 · price: Represents the average price per share.

Read SEC document
August 28, 2023 Filed Aug 28, 2023 18:27 UTC
Sardano MichaelPRESIDENT AND GENERAL COUNSEL
PurchaseCommon Stock 1,000 $2.99 $2,990.00
Disclosure

SEC source: 0001415889-23-012715 · form4-08282023_060849.xml · nonDerivative · entry 1

Sardano Michael · CIK 0001720602 · PRESIDENT AND GENERAL COUNSEL

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 58,774

Read SEC document
August 08, 2023 Filed Aug 8, 2023 18:44 UTC
Sardano MichaelPRESIDENT AND GENERAL COUNSEL
PurchaseCommon Stock 1,000 $3.78 $3,777.80
Disclosure

SEC source: 0001415889-23-011918 · form4-08082023_060806.xml · nonDerivative · entry 1

Sardano Michael · CIK 0001720602 · PRESIDENT AND GENERAL COUNSEL

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 57,774

F1 · price: Represents the average price per share.

Read SEC document
August 08, 2023 Filed Aug 8, 2023 18:43 UTC
Sardano Joseph CDirector · CHIEF EXECUTIVE OFFICER
PurchaseCommon Stock 10,000 $3.86 $38,574.00
Disclosure

SEC source: 0001415889-23-011917 · form4-08082023_060824.xml · nonDerivative · entry 1

Sardano Joseph C · CIK 0001300111 · Director · CHIEF EXECUTIVE OFFICER

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 1,165,293

F1 · price: Represents the average price per share.

Read SEC document
July 31, 2023 Filed Jul 31, 2023 14:18 UTC
Rampolla JavierCHIEF FINANCIAL OFFICER
Tax withholdingCommon Stock 3,935 $3.03 $11,923.05
Disclosure

SEC source: 0001415889-23-011594 · form4-07312023_060733.xml · nonDerivative · entry 1

Rampolla Javier · CIK 0001800068 · CHIEF FINANCIAL OFFICER

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 44,179

F1 · shares: Represents shares withheld to pay the reporting person's withholding tax obligation arising solely in connection with the vesting of restricted stock.

Read SEC document
May 11, 2023 Filed May 31, 2023 10:10 UTC PurchaseCommon Stock 10,000 $2.86 $28,600.00
Disclosure

SEC source: 0001415889-23-008954 · form4-05312023_020557.xml · nonDerivative · entry 1

Heinrich John · CIK 0001669988 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 79,940

Read SEC document
May 10, 2023 Filed May 11, 2023 14:14 UTC
Sardano Joseph CDirector · CHIEF EXECUTIVE OFFICER
PurchaseCommon Stock 7,925 $3.00 $23,735.38
Disclosure

SEC source: 0001415889-23-007766 · form4-05112023_020512.xml · nonDerivative · entry 2

Sardano Joseph C · CIK 0001300111 · Director · CHIEF EXECUTIVE OFFICER

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 1,155,293

F1 · price: Represents the average price per share.

Read SEC document
May 09, 2023 Filed May 10, 2023 11:15 UTC PurchaseCommon Stock 17,564 $3.00 $52,669.17
Disclosure

SEC source: 0001415889-23-007710 · form4-05102023_030500.xml · nonDerivative · entry 2

O'Rear Samuel · CIK 0001670026 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 143,570

Read SEC document
May 09, 2023 Filed May 11, 2023 14:14 UTC
Sardano Joseph CDirector · CHIEF EXECUTIVE OFFICER
PurchaseCommon Stock 17,075 $2.99 $51,055.96
Disclosure

SEC source: 0001415889-23-007766 · form4-05112023_020512.xml · nonDerivative · entry 1

Sardano Joseph C · CIK 0001300111 · Director · CHIEF EXECUTIVE OFFICER

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 1,147,368

F1 · price: Represents the average price per share.

Read SEC document
May 08, 2023 Filed May 10, 2023 11:15 UTC PurchaseCommon Stock 2,436 $2.95 $7,184.74
Disclosure

SEC source: 0001415889-23-007710 · form4-05102023_030500.xml · nonDerivative · entry 1

O'Rear Samuel · CIK 0001670026 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 126,006

Read SEC document
May 08, 2023 Filed May 10, 2023 13:26 UTC
Sardano MichaelPRESIDENT AND GENERAL COUNSEL
PurchaseCommon Stock 1,000 $3.00 $2,995.00
Disclosure

SEC source: 0001415889-23-007706 · form4-05102023_010547.xml · nonDerivative · entry 1

Sardano Michael · CIK 0001720602 · PRESIDENT AND GENERAL COUNSEL

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 56,774

Read SEC document
February 01, 2023 Filed Feb 3, 2023 14:19 UTC
Rampolla JavierCHIEF FINANCIAL OFFICER
Tax withholdingCommon Stock 742 $8.84 $6,559.28
Disclosure

SEC source: 0001415889-23-001898 · form4-02032023_070220.xml · nonDerivative · entry 1

Rampolla Javier · CIK 0001800068 · CHIEF FINANCIAL OFFICER

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 48,114

F1 · shares: Represents shares withheld to pay the reporting person's withholding tax obligation arising solely in connection with the vesting of restricted stock.

Read SEC document
January 26, 2023 Filed Feb 1, 2023 16:44 UTC
Sardano MichaelPRESIDENT AND GENERAL COUNSEL
Tax withholdingCommon Stock 3,745 $8.96 $33,555.20
Disclosure

SEC source: 0001415889-23-001704 · form4-02012023_040243.xml · nonDerivative · entry 2

Sardano Michael · CIK 0001720602 · PRESIDENT AND GENERAL COUNSEL

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 55,774

Read SEC document
January 26, 2023 Filed Feb 1, 2023 16:44 UTC
Sardano MichaelPRESIDENT AND GENERAL COUNSEL
GrantCommon Stock 10,000 $0.00 $0.00
Disclosure

SEC source: 0001415889-23-001704 · form4-02012023_040243.xml · nonDerivative · entry 1

Sardano Michael · CIK 0001720602 · PRESIDENT AND GENERAL COUNSEL

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 59,519

F1 · shares: Represents 10,000 shares of stock granted to the reporting person by a committee of non-employee directors in compliance with Rule 16b-3 and pursuant to the Sensus Healthcare, Inc. 2017 Equity Incentive Plan.

Read SEC document

Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.